Sandoz Inc. v. Amgen Inc.
137 S. Ct. 808, 196 L. Ed. 2d 594, 85 U.S.L.W. 3343, 2017 WL 125661, 2017 U.S. LEXIS 692
Supreme Court of the United States·Decided January 13, 2017·No. No. 15–1039.·Published·Cited by 1 cases
Opinion
Motion of Apotex, Inc., et al. for leave to file a brief as amici curiae granted. Petition for writ of certiorari to the United States Court of Appeals for the Federal Circuit granted. The case is consolidated and a total of one hour is allotted for oral argument.
Free access — add to your briefcase to read the full text and ask questions with AI
Sandoz Inc. v. Amgen Inc., 137 S. Ct. 808, 196 L. Ed. 2d 594, 85 U.S.L.W. 3343, 2017 WL 125661, 2017 U.S. LEXIS 692 (U.S. 2017).
137 S. Ct. 808 (Sandoz Inc. v. Amgen Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.
Related
Amgen Inc. v. Sandoz Inc.
877 F.3d 1315 (Federal Circuit, 2017)